Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinical Trial Enrollment

- PMLiVE

Lundbeck’s Steve Turley re-elected as EMG chair

And Actelion's Robin Bhattacherjee retains vice-chair position

Sanofi reception

Sanofi fined for slamming Plavix generics

Faces €40.6m penalty for telling doctors generic copies were not suitable substitutes for blockbuster antiplatelet drug

- PMLiVE

FDA expands use of Roche/ Astellas’ Tarceva in lung cancer patients

New indication approved alongside companion diagnostic to detect gene mutation

- PMLiVE

Merck KGaA to meet 2014 financial targets one year early

But continued growth of Rebif under threat from new oral MS drugs

- PMLiVE

VC firm expands team, appoints Genzyme and Lilly veterans

New roles for James Geraghty, Steven Paul, Daniel Lynch and John Maraganore

- PMLiVE

Brazil eHealth pilot improves healthcare access for city poor

Rio de Janeiro project also finds eHealth integration provides major cost savings for health system

- PMLiVE

Damian Eade to lead Insight Research Group’s new digital team

New business team will focus on mobile, strategy and new channels

- PMLiVE

The impact of Hollande’s healthcare reforms in France

A tougher environment for pharma, with market access and regulatory challenges

GSK partners with Save the Children to tackle child mortality in Africa

Firm will develop and distribute medicines in some of the world’s poorest countries 

- PMLiVE

New guidelines allow brands to majority fund health campaigns

UK government departments no longer have to match funding from external partners

Biogen Idec building

FDA starts review of Biogen Idec’s haemophilia A therapy

Could gain US approval by the first quarter of 2014

- PMLiVE

Research units to close as Astellas restructures

US subsidiaries OSI Pharmaceuticals and Perseid Therapeutics among those affected

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links